Last reviewed · How we verify

NCT04000412

A Novel Myocardial Impedance Mapping System for Ablation of Post-infarction Ventricular Arrhytmias in Humans

Status unknown Last updated 27 June 2019
What this trial tests

trial testing CardioZ multifrequency impedance recording system in Ventricular Arrythmia in 25 participants. Status unknown.

Timeline
19 March 2019
Primary endpoint
4 February 2022
25 February 2022

Quick facts

Lead sponsorFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment25
Start date19 March 2019
Primary completion4 February 2022
Estimated completion25 February 2022
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Who can join

18 and older, any sex, with Ventricular Arrythmia or Infarction, Myocardial. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Precise identification of the infarct scar is essential for successful catheter ablation of ventricular arrhythmias in patients with chronic myocardial infarction. Voltage mapping of endocardial electrograms is currently used to delineate the necrotic scar but this is influenced by the direction of the activation wave front and is not sensitive enough to differentiate distinct degrees of transmural injury in the scar. Mapping of local myocardial electrical impedance may overcome these limitations.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Ventricular Arrythmia

Currently open trials in the same condition.

Other Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04000412.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing